Ensysce Biosciences Inc (ENSC)

[StockLogistics]

If Oxy addiction solved, make millions, it is that simple, drug addiction talked about in media everyday is free advertising if this drug works:

“1:52p ET 1/25/2023 - Dow Jones
Ensysce Biosciences Shares Soar 37% on Final Study Stage Initiation of PF614-MPAR

Ensysce Biosciences Inc. shares soared 37% to 93 cents after the company said it initiated the final stage of its Phase 1 study of PF614-MPAR, the overdose protection version of its lead product, PF614.

The clinical stage biotech company said the selected PF614-MPAR formulation will be evaluated by measuring oxycodone release from increasing dose units delivered to a group of healthy subjects in the final stage of the study.

Ensysce said PF614-MPAR is designed to provide optimal pain relief at prescribed doses, while PF614 is a prodrug of oxycodone designed to protect against prescription drug abuse.

Trading on Wednesday was paused for volatility four times and resumed most recently at 10:09 a.m. EDT. Roughly 62.1 million shares had traded as of 1:34 p.m. EDT, compared with its 65-day average volume of roughly 1.3 million shares.

Shares are down 98% over the last 12 months.”